Related Experiment Videos
[Familial LCAT deficiency--clinical picture. Case report].
B Idzior-Waluś1, J Sieradzki, W Rostworowski
1Katedra i Klinika Chorób Metabolicznych Collegium Medicum UJ w Krakowie.
Polskie Archiwum Medycyny Wewnetrznej
|June 8, 2001
Summary
Familial lecithin-cholesterol acyltransferase (LCAT) deficiency is a rare genetic disorder. This case highlights key diagnostic features including proteinuria, corneal opacities, and hemolytic anemia.
Area of Science:
- Biochemistry
- Genetics
- Nephrology
Background:
- Familial lecithin-cholesterol acyltransferase (LCAT) deficiency is a rare inherited disorder affecting lipid metabolism.
- LCAT enzyme is crucial for cholesterol esterification, a key step in high-density lipoprotein (HDL) maturation.
Observation:
- A 35-year-old woman presented with proteinuria, corneal opacities, and hemolytic anemia with target cells.
- Renal biopsy revealed characteristic serpiginous fibrillar deposits on electron microscopy, raising suspicion for familial LCAT deficiency.
Findings:
- Diagnosis was confirmed by significantly decreased serum esterified cholesterol and low HDL-cholesterol levels.
- Reduced serum LCAT activity and a distinctive "stacked coins" appearance of HDL lipoproteins were observed.
- A positive family history, including a brother diagnosed with LCAT deficiency, supported the diagnosis.
Implications:
- This case underscores the importance of considering familial LCAT deficiency in patients with unexplained renal disease and dyslipidemia.
- Early diagnosis and understanding of LCAT deficiency are vital for managing associated complications like renal failure.
- Further research into LCAT deficiency can elucidate its role in lipoprotein metabolism and disease pathogenesis.